BNP PARIBAS ASSET MANAGEMENT Holding S.A. Cuts Stock Holdings in Colgate-Palmolive (NYSE:CL)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 6.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 880,498 shares of the company’s stock after selling 64,647 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned approximately 0.11% of Colgate-Palmolive worth $91,404,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CL. E Fund Management Hong Kong Co. Ltd. purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC grew its stake in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the third quarter worth $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of Colgate-Palmolive stock opened at $93.91 on Thursday. The company has a fifty day simple moving average of $98.56 and a 200-day simple moving average of $98.52. Colgate-Palmolive has a 12-month low of $75.39 and a 12-month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a market cap of $76.73 billion, a price-to-earnings ratio of 26.91, a PEG ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.13%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on CL. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. UBS Group upped their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Barclays lifted their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Finally, TD Cowen dropped their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.